Free Trial

Pyxis Oncology (PYXS) SEC Filings & 10K Form

Pyxis Oncology logo
$0.94 -0.08 (-7.84%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.92 -0.02 (-2.55%)
As of 05:11 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Pyxis Oncology SEC Filings

DateFilerForm TypeView
04/02/2025
8:25 PM
Pyxis Oncology (Subject)
Sullivan Lara (Filed by)
Form SCHEDULE 13D/A
04/02/2025
7:55 AM
FLAVIN JOHN L (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:56 AM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:57 AM
Civik Thomas (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:58 AM
Palani Santhosh (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:00 AM
Dupont Jakob (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:01 AM
Cline Darren S (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:02 AM
Lewis-Hall Freda C (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:03 AM
HUMPHREY RACHEL (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:04 AM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:05 AM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
8:06 AM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
6:43 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:48 PM
Pyxis Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2025
6:57 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
7:03 AM
Pyxis Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
6:39 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
7:48 AM
Deep Track Capital, LP (Filed by)
Pyxis Oncology (Subject)
Form SCHEDULE 13G/A
02/04/2025
6:40 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
5:31 PM
Pyxis Oncology (Subject)
Sullivan Lara (Filed by)
Form SCHEDULE 13D/A
12/23/2024
3:30 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:33 PM
Pyxis Oncology (Issuer)
Sullivan Lara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
3:26 PM
Pyxis Oncology (Issuer)
Wadhane Jitendra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
4:07 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2024
4:09 PM
Connealy Pamela Ann (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:53 AM
Laurion Capital Management LP (Filed by)
Pyxis Oncology (Subject)
Form SC 13G/A
10/23/2024
3:53 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2024
3:08 PM
Pyxis Oncology (Filer)
Form DEF 14A
09/13/2024
3:26 PM
Pyxis Oncology (Filer)
Form PRE 14A
08/14/2024
3:25 PM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/12/2024
3:17 PM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
4:31 PM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:26 PM
Metzger Michael A (Reporting)
Pyxis Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/10/2024
6:56 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
6:55 AM
Pyxis Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
7:00 AM
Pyxis Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/26/2024
3:16 PM
Pyxis Oncology (Filer)
Form ARS
04/26/2024
3:15 PM
Pyxis Oncology (Filer)
Form DEF 14A
04/26/2024
3:16 PM
Pyxis Oncology (Filer)
Form DEFA14A
04/03/2024
11:15 PM
Pyxis Oncology (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:PYXS) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners